STONY BROOK, N.Y., December 6, 2018 Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA,” the “Company”), the leader in large-scale PCR-based DNA manufacturing, today announced that Dr. James Hayward, president & CEO, will present at the Long Island Capital Alliance’s Cannabis Capital Forum (the “Forum”) in Melville, N.Y., on Friday, December 7 at 9:00 AM ET. Management’s presentation materials at the Forum will be made available on the Company’s Investor Relations website at http://adnas.com/adnas_home/investors shortly prior to presentation start.

About Applied DNA Sciences

Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and DNA mass production for diagnostics and therapeutics.

Applied DNA makes life real and safe by providing innovative, molecular-based technology solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion.

Visit adnas.com for more information. Follow us on Twitter and LinkedIn. Join our mailing list.

The Company’s common stock is listed on NASDAQ under the symbol APDN, and its warrants are listed under the symbol APDNW.

Investor Contact: Sanjay M. Hurry, LHA Investor Relations, 212-838-3777, shurry@lhai.com
Cannabis Program Contacts: John Shearman, Executive Director, Marketing, 631-240-8838, john.shearman@adnas.com
Gordon Hope, Director, Cannabis Business Development, 631-240-8850, gordon.hope@adnas.com
Web: www.adnas.com
Twitter: 
@APDN